CAITLIN UNDERKOFFLER: Open Payments
NPI 1174302467 · FLOURTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 51 payments from 20 companies in 2025. Trend: 2023 $107 · 2024 $459 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $251 |
| ABBVIE INC. | 10 | $140 |
| Sumitomo Pharma America, Inc. | 5 | $128 |
| Phathom Pharmaceuticals, Inc. | 7 | $84 |
| Ardelyx, Inc. | 2 | $55 |
| Madrigal Pharmaceuticals | 1 | $53 |
| Olympus America Inc. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $41 |
| GENZYME CORPORATION | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $33 |
Products named: TREMFYA, GEMTESA, ERLEADA, VOQUEZNA, IBSRELA, REZDIFFRA, DUPIXENT, iTIND System.
Industry payments across PA — which companies pay providers there.
